Literature DB >> 1652597

Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women.

J G Regensteiner1, W R Hiatt, R L Byyny, C K Pickett, W D Woodard, L G Moore.   

Abstract

Blood pressure rises in women with increasing age, possibly related to the decrease in production of female hormones that accompanies menopause. Although estrogen or progestin administration alone consistently does not lower blood pressure in postmenopausal women, possible interactions of these two hormones in affecting blood pressure are not well understood. We studied 12 surgically postmenopausal, normotensive women, aged 51 +/- 2 years (SEM). Treatment for each subject consisted of 1 week each of placebo, estrogen (conjugated equine estrogens, 2.5 mg/day), progestin (medroxyprogesterone acetate, 60 mg/day), and combined estrogen and progestin, given in varied order. At the end of each week, auscultatory blood pressures were measured while patients were seated. Neither estrogen nor progestin alone either increased or decreased blood pressure significantly, whereas combined estrogen and progestin lowered systolic, diastolic, and mean blood pressures 6 to 7 mm Hg (P less than .05). Treatment order was unrelated to the change in blood pressure values. The authors suggest that administering progestin with estrogen may be more effective in lowering blood pressure than either hormone alone in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652597     DOI: 10.1002/j.1552-4604.1991.tb03735.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  3 in total

1.  NAD(P)H:quinone oxidoreductase 1 is induced by progesterone in cardiomyocytes.

Authors:  Stephen Morrissy; Joshua Strom; Sally Purdom-Dickinson; Qin M Chen
Journal:  Cardiovasc Toxicol       Date:  2012-06       Impact factor: 3.231

2.  Cardiac dysfunction during exercise in uncomplicated type 2 diabetes.

Authors:  Judith G Regensteiner; Timothy A Bauer; Jane E B Reusch; Robert A Quaife; Marcus Y Chen; Susan C Smith; Tyler M Miller; Bertron M Groves; Eugene E Wolfel
Journal:  Med Sci Sports Exerc       Date:  2009-05       Impact factor: 5.411

3.  Downregulation of CYP17A1 by 20-hydroxyecdysone: plasma progesterone and its vasodilatory properties.

Authors:  Maneera Y Aljaber; Nelson N Orie; Asmaa Raees; Suhail Kraiem; Mashael Al-Jaber; Waseem Samsam; Mostafa M Hamza; David Abraham; Norman M Kneteman; Alka Beotra; Vidya Mohamed-Ali; Mohammed Almaadheed
Journal:  Future Sci OA       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.